Patent US5512055A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5512055A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-infective and anti-inflammatory releasing systems for medical devices

Assignee: MARYLAND BIOPOLYMER TECHNOLOGIES LLC
•
Filing: 1994-09-30
•
Granted: 1996-04-30
•
Expires: 2014-09-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Devices are provided having a polymer coating incorporating compounds inhibiting inflammation and infection, along with subsequent tissue growth onto and around the device. Preferred embodiments include catheters, tubes, and implants that abut tissue following implantation into the body, especially for use in the naso-oto-pharyngeal areas of the body, where localized chronic infection/inflammation of the tissues surrounding the implant may be decreased by sustained release of antibiotics, antifungals, antivirals, anti-inflammatories, and other compounds, such as anticoagulants and anesthetics. Preferred polymeric coatings are thin, well adhered to the underlying device, and formed of a biocompatible, non-bioerodible polymer such as polyurethane or ethylene vinyl acetate. The drug is incorporated either by solvent casting or by absorption into the solidified polymer. The drug incorporated polymer can also be used to form devices, or portions of devices, for implantation.

Inventors

  • 👤 Abraham J. Domb
  • 👤 Alain Shikani
  • 👤 Andrew S. T. Haffer
  • 👤 Manoj Maniar

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:44
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61L; A61L27/00; A61L27/50; A61L27/54; A61L29/00; A61L29/14; A61L29/16; A61L2300/00; A61L2300/10; A61L2300/106; A61L2300/40; A61L2300/402; A61L2300/404; A61L2300/406; A61L2300/408; A61L2300/41; A61L2300/42; A61L2300/60; A61L2300/602; A61L2300/606; A61M; A61M16/00; A61M16/04; A61M16/0465

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 86 words
A medical device for implantation into tissue comprising, in combination, the device having exterior surfaces, a biocompatible, nonbioerodible polymer dissolved in a solvent to form a solution, the solution being disposed on the exterior surface of the device and the solvent removed to form a uniform coating on the medical device, the polymer coating having a biologically active agent sorbed therein to be released over a period of at least twenty-four hours by diffusion when implanted in the tissue, wherein said biologically active agent is iodine.
Claim 2
Dependent Claim 86 words
A medical device for implantation into tissue comprising, in combination, the device having exterior surfaces, a biocompatible, nonbioerodible polymer dissolved in a solvent to form a solution, the solution being disposed on the exterior surface of the device and the solvent removed to form a uniform coating on the medical device, the polymer coating having a biologically active agent sorbed therein to be released over a period of at least twenty-four hours by diffusion when implanted in the tissue, wherein said biologically active agent is iodine.
Claim 3
Dependent Claim 25 words
The medical device of claim 1, wherein the polymer is selected from the group consisting of polyurethane, ethylene vinyl acetate, silicones, hydrogels, and polyvinyl chloride.
Claim 4
Dependent Claim 45 words
The medical device of claim 1, further comprising a second polymer coating disposed on the polymer coating having the biologically-active agent sorbed therein, the biologically active agent being absent in the second polymer coating, whereby release of the biologically-active agent by diffusion is further controlled.
Claim 5
Dependent Claim 64 words
The medical device of claim 1, wherein the biologically active agent is dissolved in a second solvent to form a second solution, and the polymer coated medical device being immersed in the second solution permitting the biologically active agent to be sorbed in the coating, thereby providing a controlled rapid release of the biologically active agent over a period of at least twenty-four hours.
Claim 6
Dependent Claim 23 words
The medical device of claim 1, wherein the solvent is selected from the group consisting of dichloromethane, tetrahydrofuran, methylene chloride and methyl chloroform.
Claim 7
Dependent Claim 95 words
A medical device for implantation into tissue comprising, in combination, the device having exterior surfaces, a biocompatible, nonbioerodible polymer dissolved in a solvent to form a solution, a biologically active agent dissolved in said solution, the solution being disposed on the exterior surface of the device, and the solvent removed to form a uniform coating on the medical device such that polymer coating having the biologically active agent solvent casted therein is released by diffusion over a period of at least two days when implanted in the tissue, wherein said biologically active agent is iodine.
Claim 8
Dependent Claim 95 words
A medical device for implantation into tissue comprising, in combination, the device having exterior surfaces, a biocompatible, nonbioerodible polymer dissolved in a solvent to form a solution, a biologically active agent dissolved in said solution, the solution being disposed on the exterior surface of the device, and the solvent removed to form a uniform coating on the medical device such that polymer coating having the biologically active agent solvent casted therein is released by diffusion over a period of at least two days when implanted in the tissue, wherein said biologically active agent is iodine.
Claim 9
Dependent Claim 25 words
The medical device of claim 6, wherein the polymer is selected from the group consisting of polyurethane, ethylene vinyl acetate, silicones, hydrogels, and polyvinyl chloride.
Claim 10
Dependent Claim 46 words
The medical device of claim 6, further comprising a second polymer coating disposed on the polymer coating having the biologically-active agent solvent casted therein the biologically active agent being absent in the second polymer coating, whereby release of the biologically-active agent by diffusion is further controlled.
Claim 11
Dependent Claim 97 words
A medical device for implantation into tissue comprising, in combination, the device having exterior surfaces, a biocompatible, nonbioerodible polymer, being dissolved in a solvent to form a solution, the solution further having a biologically active agent dissolved therein, the solution being disposed on the device, the solvent being removed and forming a single uniform coating on the device wherein the biologically active agent is released by diffusion when the coated device is in contact with the tissue, said release being controlled over a period of at least twenty-four hours and wherein said biologically active agent is iodine.
Claim 12
Dependent Claim 97 words
A medical device for implantation into tissue comprising, in combination, the device having exterior surfaces, a biocompatible, nonbioerodible polymer, being dissolved in a solvent to form a solution, the solution further having a biologically active agent dissolved therein, the solution being disposed on the device, the solvent being removed and forming a single uniform coating on the device wherein the biologically active agent is released by diffusion when the coated device is in contact with the tissue, said release being controlled over a period of at least twenty-four hours and wherein said biologically active agent is iodine.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-04-30 1999-10-30 2000-04-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-04-30 2003-10-30 2004-04-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-04-30 2007-10-30 2008-04-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag